ASCO 2019 | Individualized therapy in waldenström’s macroglobulinemia

Jithma Abeykoon

Jithma Abeykoon, MD, PhD, of the Mayo Clinic, Rochester, MN, explains the importance of individualized therapy in waldenström’s macroglobulinemia. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video